Equity Compensation (Tables)
|
9 Months Ended |
Jan. 31, 2026 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Non Qualified Stock Option |
A
summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the period from June 7, 2025 through January
31, 2026, are presented in the tables below:
Schedule of Non Qualified Stock Option
| | |
Number
of
Options | | |
Weighted
Average
Exercise
Price | | |
Weighted
Average
Remaining Contractual Term
(in years) | | |
Aggregate
Intrinsic
Value | |
| | |
| | |
| | |
| | |
| |
| Outstanding, June 7, 2025 | |
| 4,760 | | |
$ | 113.34 | | |
| 3.53 | | |
$ | - | |
| Granted | |
| - | | |
| - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited | |
| - | | |
| - | | |
| - | | |
| - | |
| Expired | |
| (1,111 | ) | |
| 52.2 | | |
| - | | |
| - | |
| Outstanding, January 31, 2026 | |
| 3,649 | | |
$ | 131.95 | | |
| 3.94 | | |
$ | - | |
| Exercisable, January 31, 2026 | |
| 3,649 | | |
$ | 131.95 | | |
| 3.94 | | |
$ | - | |
|
| Schedule of Restricted Units Activity |
Schedule of Restricted Units Activity
| | |
Number
of
Units | | |
Weighted
Average
Grant-Date
Fair
Value | |
| | |
| | |
| |
| Unvested, June 7, 2025 | |
| 1,529 | | |
$ | 8.18 | |
| Granted | |
| 5,320 | | |
| 9.40 | |
| Vested and settled with share issuance | |
| (4,189 | ) | |
| - | |
| Forfeited/cancelled | |
| (1,330 | ) | |
| 9.40 | |
| Unvested, January 31, 2026 | |
| 1,330 | | |
$ | 8.89 | |
|
| Schedule of Warrant Activity |
Strategic
Advisor warrants and Asset Manager warrants are accounted for as equity classified share-based compensation award in accordance with
ASC 718. Following is a summary of the activities of warrants for the period ended January 31, 2026:
Schedule of Warrant Activity
| | |
Number
of
Warrants | | |
Weighted
Average
Exercise
Price | | |
Aggregate
Intrinsic
Value | |
| Outstanding as of June 7, 2025 | |
| - | | |
$ | - | | |
$ | - | |
| Granted | |
| 6,930,697 | | |
| 1.46 | | |
| | |
| Exercised | |
| 2,376,236 | | |
| 0 | | |
| | |
| Forfeited | |
| - | | |
| - | | |
| | |
| Expired | |
| - | | |
| - | | |
| | |
| Outstanding as of January 31, 2026 | |
| 4,554,461 | | |
$ | 2.22 | | |
$ | 17,786,131 | |
| Exercisable as of January 31, 2026 | |
| 4,554,461 | | |
$ | 2.22 | | |
$ | 17,786,131 | |
|
| Schedule of Key Assumption Inputs |
The
table below summarizes the key assumption inputs used for the valuation for the period from June 7, 2025 through January 31, 2026:
Schedule of Key Assumption Inputs
| | |
Asset Manager Warrants | |
| Stock price | |
$ | 17.7 | |
| Exercise price | |
$ | 10.23 | |
| Expected term (in years) | |
| 5 | |
| Risk-free interest rate | |
| 3.77 | % |
| Expected volatility | |
| 110 | % |
| Expected dividend yield | |
| 0 | % |
|
| 2017 Equity Plan and 2021 Equity Plan [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Stock Option Activity |
A
summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity
Plans during the period from June 7, 2025 through January 31, 2026, are presented in the tables below:
Schedule of Stock Option Activity
| | |
Number of
Options | | |
Weighted
Average
Exercise Price | | |
Weighted
Average
Remaining Contractual Term
( in years) | | |
Aggregate
Intrinsic Value | |
| | |
| | |
| | |
| | |
| |
| Outstanding as of June 7, 2025 | |
| 18,296 | | |
$ | 83.19 | | |
| 5.17 | | |
$ | - | |
| Granted | |
| 2,700 | | |
| 7.74 | | |
| 9.36 | | |
| - | |
| Exercised | |
| - | | |
| 0.00 | | |
| - | | |
| - | |
| Forfeited | |
| (450 | ) | |
| 7.74 | | |
| - | | |
| - | |
| Expired | |
| (2,086 | ) | |
| 27.72 | | |
| - | | |
| - | |
| Outstanding as of January 31, 2026 | |
| 18,460 | | |
$ | 79.45 | | |
| 5.64 | | |
$ | - | |
| Exercisable as of January 31, 2026 | |
| 16,211 | | |
$ | 89.41 | | |
| 5.12 | | |
$ | - | |
|